Search

everythinglearnresearchcommunity

for

Search:↓

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

The technique effectively promotes hair growth in young men with androgenetic alopecia.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Testosterone increases cell growth and reduces IL-6 in gum cells.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

A new method accurately measures nine specific hormones in human blood.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Botulinum toxin may help treat male pattern baldness.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Applying estradiol to skin causes local changes but not cancer.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.